Percutaneous transthoracic Bard biopsy instrument in pathologic diagnosis for advanced lung cancer

CHENG Zhenshun,YE Yanqing,LIN Yuhui,ZOU Shiqing,YANG Yibin,LIU Weimin,WU Kaisong,DU Chunxian,XU Qiyong,YANG Jiong
IF: 5.41
2008-01-01
Clinical Medicine
Abstract:Objective To study the clinical application of Bard disposable biopsy instrument in the pathologic diagnosis for advanced lung cancer.Methods Thirty-five patients were dignosed as having advanced lung cancer staged Ⅲa-Ⅳ by chest X-ray,computed tomography,for which a pathologic diagnosis was not made by sputum and bronchoscopic examination.CT-guided Bard disposable biopsy instrument percutaneous transthoracic biopsy was performed in order to obtain the pathology diagnosis of pulmonary lesions.Results Pathologic samples were obtained in 33 of the 35 patients by Bard disposable biopsy instrument percutaneous transthoracis biopsy.The successful rate was 94%,After operation,the pathologic diagnosis was confirmed to be lung cancer in 31 patients.Adenocarcinoma was found in 20 patients,squamous carcinoma in 9,alveolar cell carcinoma in 1 and small cell lung cancer in 1.Inflammatory pseudotumor in 1,1 case was not clear.Pneumothorax and mild haemoptysis occurred in 2 patients and 1 of the case respectively.Conclusion Bard disposable biopsy instrument percutaneous transthoracic biopsy is an effective diagnostic measure for patients with advanced lung cancer for which pathologic diagnosis is not determined by routine examinations.
What problem does this paper attempt to address?